iSERA Lifesciences Ltd

AI
iSERA Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

iSERA Lifesciences Ltd

₹ 144 0.00%
23 Oct - close price
covidh.co.in BSE: 534920
About

Incorporated in 1993, Covidh Technologies Ltd is engaged in IT/ITES business.[1]

Key Points

Business Overview:[1]
CTL is in the business of providing Information
Technology / Information Technology Enabled Services.

Website BSE
  • Market Cap ₹ 354 Cr.
  • Current Price ₹ 144
  • High / Low ₹ 151 / 7.99
  • Stock P/E
  • Book Value ₹ 0.02
  • Dividend Yield 0.00 %
  • ROCE 3.40 %
  • ROE -7.92 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 8,262 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -3.56%
  • The company has delivered a poor sales growth of -6.47% over past five years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 203 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Software Computers - Software & Consulting

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
0.15 2.97 1.97 3.87 2.24 4.43 6.24 13.79 10.43 7.42 4.21 3.62 1.11
2.27 2.88 1.95 3.81 1.66 4.23 6.02 13.59 10.35 7.32 4.12 3.41 1.11
Operating Profit -2.12 0.09 0.02 0.06 0.58 0.20 0.22 0.20 0.08 0.10 0.09 0.21 -0.00
OPM % -1,413.33% 3.03% 1.02% 1.55% 25.89% 4.51% 3.53% 1.45% 0.77% 1.35% 2.14% 5.80% -0.00%
0.03 0.02 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Interest -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.09 0.05 0.11 0.09 0.13 0.06
Depreciation 0.06 0.06 0.02 0.02 0.56 0.09 0.09 0.12 -0.00 0.02 0.01 0.09 -0.00
Profit before tax -2.15 0.05 -0.00 0.04 0.02 0.11 0.13 -0.01 0.03 -0.03 -0.01 -0.01 -0.06
Tax % -29.77% 40.00% 25.00% -200.00% 27.27% 30.77% -100.00% 33.33% -0.00% -0.00% 100.00% -0.00%
-1.51 0.04 -0.00 0.03 0.06 0.08 0.09 -0.00 0.02 -0.03 -0.01 -0.03 -0.06
EPS in Rs -0.05 0.00 -0.00 0.00 0.00 0.00 0.00 -0.00 0.00 -0.00 -0.00 -0.00 -0.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019 TTM
6.29 25.85 35.89 11.06 25.50 33.57 25.69 16.36
6.21 22.74 35.37 10.28 25.14 33.10 25.21 15.96
Operating Profit 0.08 3.11 0.52 0.78 0.36 0.47 0.48 0.40
OPM % 1.27% 12.03% 1.45% 7.05% 1.41% 1.40% 1.87% 2.44%
0.03 0.07 -0.00 -0.00 -13.45 -0.00 -0.00 0.00
Interest -0.00 0.02 0.02 0.01 0.16 0.27 0.38 0.39
Depreciation 0.02 0.19 0.31 0.66 0.14 0.19 0.12 0.12
Profit before tax 0.09 2.97 0.19 0.11 -13.39 0.01 -0.02 -0.11
Tax % 33.33% 35.35% 42.11% -9.09% 0.22% 100.00% 100.00%
0.06 1.93 0.11 0.13 -13.42 0.01 -0.04 -0.13
EPS in Rs 0.07 0.00 0.00 -0.49 0.00 -0.00 0.00
Dividend Payout % -0.00% 27.46% -0.00% -0.00% -0.00% -0.00% -0.00%
Compounded Sales Growth
10 Years: %
5 Years: -6%
3 Years: 0%
TTM: -23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -13%
TTM: -500%
Stock Price CAGR
10 Years: 42%
5 Years: 164%
3 Years: 306%
1 Year: 1351%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019
Equity Capital 3.60 10.60 10.60 10.60 10.60 10.60 10.60
Reserves 1.72 3.14 3.24 3.37 -10.05 -10.07 -10.12
-0.00 2.35 5.64 6.33 7.51 9.51 10.64
2.00 6.15 5.76 4.52 6.41 9.88 6.54
Total Liabilities 7.32 22.24 25.24 24.82 14.47 19.92 17.66
0.07 5.56 6.37 7.90 0.71 0.61 0.87
CWIP 4.06 6.34 5.36 4.23 -0.00 -0.00 -0.00
Investments 0.69 0.18 0.18 0.28 -0.00 -0.00 -0.00
2.50 10.16 13.33 12.41 13.76 19.31 16.79
Total Assets 7.32 22.24 25.24 24.82 14.47 19.92 17.66

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019
-0.03 -1.94 0.49 0.81 -0.65 -0.33
-0.00 -7.44 -1.16 -0.40 -0.16 -0.38
-0.00 9.45 0.69 -0.42 0.80 1.13
Net Cash Flow -0.03 0.07 0.03 -0.01 -0.01 0.42
Free Cash Flow -0.03 -5.43 0.09 0.41 -0.65 -0.33
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -38% -62% 63% 225% -136% -65%

Ratios

Consolidated / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019
Debtor Days 137.53 114.65 111.36 274.58 157.16 185.27 203.31
Inventory Days -0.00 -0.00
Days Payable
Cash Conversion Cycle 137.53 114.65 111.36 274.58 157.16 185.27 203.31
Working Capital Days 29.01 55.91 77.19 260.38 81.87 83.39 102.86
ROCE % 27.93% 1.18% 0.60% 1.55% 3.40%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Turnover (Foreign Exchange Earnings)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Number of Subsidiaries
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Oct 2026
26.35% 26.35% 26.35% 26.35% 92.76% 92.76% 92.76% 3.57% 58.63% 58.63% 58.63% 55.07%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.01%
73.65% 73.65% 73.65% 73.65% 7.24% 7.24% 7.24% 96.43% 41.38% 41.37% 41.35% 44.92%
No. of Shareholders 2,5302,5302,5302,5309329329361,0341,0291,0141,0111,181

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports